We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 31.00
Bid: 30.00
Ask: 32.00
Change: 0.50 (1.64%)
Spread: 2.00 (6.667%)
Open: 31.00
High: 31.00
Low: 31.00
Prev. Close: 30.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Replacement: Trading update

17 Mar 2017 18:25

RNS Number : 8736Z
Ilika plc
17 March 2017
 

A number of non material typographical changes have been made to the 'Trading update' announcement released on 17 March 2017 at 07.00 under RNS No 7455Z.

 

The changes are identified with an asterisk (*).

 

The full amended text is shown below.

 

17 March 2017

Ilika plc

("Ilika" or the "Company")

 

Trading update

 

Ilika (AIM: IKA), a pioneer in materials innovation and solid-state battery technology, announces the following update on trading.

 

Revenue update

Since its last trading update in November 2016, the Company has announced four significant commercial deals, which are resulting in a strong ramp-up of revenue relative to 2015/16 and which will continue to support revenue growth into 2017/18. We expect to start 2017/18 with a record level of revenue commitments amounting to around £1.8m.

 

Ilika's stated business aim is to add licensing revenue to the development revenue it currently generates. While levels of interest are encouraging, predicting the timing of when these licenses will generate revenue remains a significant forecasting challenge for the Company. Given our proximity to the end of Ilika's current financial year and the duration of negotiations with OEM potential licensees, it seems increasingly likely that revenue from licensing may first have an impact in 2017/18.

 

Stereax roadmap update

Ilika has continued to develop its Stereax intellectual property in accordance with its roadmap, which it updates in line with feedback from its pipeline of development partners. Earlier this month, Ilika confirmed that it had secured a partnership with a bioelectronics company*, focused on optimising the Stereax platform for use in miniature medical implants*. Bioelectronics is a rapidly developing market with large opportunities that match the unique benefits that Stereax offers. Stereax's high volumetric energy density, manufacturability at mm-scale and the ability to deliver pulses of power are ideal for such devices. *

 

Towards the end of last year, Ilika announced the start of a funded collaborative project with Sharp Laboratories of Europe ("Sharp") to create a device consisting of an integrated StereaxTM solid-state battery and a photovoltaic panel, offering an autonomous energy harvesting device for wireless components. The initial concept was designed to address opportunities in automotive and wearables, but publicity around the project has also attracted interest from consumer goods companies looking for innovative ways to promote their products in retail outlets.

 

The next product milestone on Ilika's Stereax roadmap is its industrial battery, code-named Endeavour, which will be able to operate in an extended temperature range covering -40 to 150 degree Celsius. This battery is designed to meet the requirements of Industrial IoT, sometimes called Industry 4.0. A discussion of applications is covered in our recently-posted video featuring Meggitt and IBM which can be found here - http://www.ilika.com/news/videos.

 

Materials development programmes

While the Company is deploying most of its operational and commercial resources on Stereax activities, it has also seen an increase in materials development programmes on its high throughput technology platform. Last month Ilika announced that it had received notification of a renewal of the commercial relationship it has with Seagate to develop photonic materials and processes for Hard Disk Drive ("HDD") technology.

 

Ilika has also recently announced the renewal and strengthening of its long-standing relationship with Toyota. This has been triggered by the award of a contract by the Toyota Research Institute in the USA, which was founded at the end of 2015 with an initial focus on artificial intelligence, robotics and materials innovation.

 

The Company will announce a more detailed update on the outturn for 2016/17 in May prior to issuing its full year results in July.

 

Graeme Purdy, CEO of Ilika, commented: "We are continuing to see a reinforcement of our customer relationships, with long-standing partnerships with companies like Toyota and Seagate being further cemented. It's also great to see the upturn in revenues relative to last year allowing us to start 2017/18 with such a strong order book. The number of potential licensees, their level of interest and the diversity of applications is giving us growing confidence in our licensing model."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan/ Paul Gillam (Corporate Adviser)

 

James Black/ Michael Burke (Corporate Broking)

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIGDXCBBBGRR
Date   Source Headline
24th Sep 20142:37 pmRNSHolding(s) in Company
24th Sep 20141:00 pmRNSResult of AGM
24th Sep 20147:00 amRNSAGM Statement
23rd Sep 20143:36 pmRNSHolding(s) in Company
23rd Sep 20147:00 amRNSSuccessful Factory Acceptance Test
27th Aug 20147:04 amRNSPosting of Annual Report & Notice of AGM
14th Aug 20147:00 amRNSContract win
23rd Jul 201410:05 amRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
14th Jul 201412:21 pmRNSConversion of preference shares
11th Jul 20147:00 amRNSProof of Concept Contract Win
10th Jul 20147:00 amRNSCancellation of Conversion of securities
1st Jul 20147:00 amRNSIncrease in Solid-State Battery Size Achieved
20th Jun 20147:00 amRNSNotice of Results
12th May 201411:15 amRNSConversion of Securities
7th May 20147:00 amRNSUK Patents Grants
6th May 201410:28 amRNSConversion of Securities
30th Apr 20145:05 pmRNSConversion of securities and Director Dealings
14th Apr 20142:54 pmRNSConversion of Securities
14th Mar 20145:49 pmRNSHolding(s) in Company
13th Mar 20145:38 pmRNSConversion of Securities
12th Mar 20142:14 pmRNSHolding(s) in Company
12th Mar 20141:14 pmRNSHolding(s) in Company
10th Mar 20144:52 pmRNSHolding(s) in Company
6th Mar 20144:08 pmRNSTotal Voting Rights
26th Feb 20143:50 pmRNSHolding(s) in Company
20th Feb 20147:05 amRNSExercise of warrants
20th Feb 20147:00 amRNSPlacing
14th Feb 20143:45 pmRNSConversion of Securities
11th Feb 20147:00 amRNSGrant funding for Superalloys
10th Feb 20147:00 amRNSCommercial Update & Conversion of Securities
30th Jan 20144:28 pmRNSHolding(s) in Company
28th Jan 20145:04 pmRNSHolding(s) in Company
28th Jan 201411:30 amRNSHolding(s) in Company
28th Jan 20147:00 amRNSValidation of Worlds 1st Solid State Battery
24th Jan 201411:05 amRNSHolding(s) in Company
23rd Jan 20144:50 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHolding(s) in Company
15th Jan 20147:00 amRNSInterim Results
13th Jan 20144:28 pmRNSHolding(s) in Company
10th Jan 20144:09 pmRNSHolding(s) in Company
9th Jan 20147:00 amRNSWorld first for Ilika solid state battery
13th Dec 20137:00 amRNSFuel Cell Catalyst Patent Granted in Europe
2nd Dec 20134:16 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSHalf Year Trading Update
28th Oct 20137:00 amRNSIlika expands into Aerospace Sector
21st Oct 20137:00 amRNSInvestor Teach-in
17th Sep 20134:09 pmRNSResult of AGM
17th Sep 20137:00 amRNSAGM Statement
16th Sep 20137:00 amRNSTwo New Customers in Europe

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.